Cephalon, Inc. v. Watson Pharmaceuticals, Inc.

Procedural entryThis page is a short order in Cephalon, Inc. v. Watson Pharmaceuticals, Inc.. Read the opinion of the Court — 707 F.3d 1330
Court of Appeals for the Federal Circuit·Decided March 29, 2012·No. 2011-1325·Unpublished

Opinion

NOTE: This order is nonprecedential. “ United States Court of AppeaIs for the FederaI Circuit CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants, V. WATSON PHARM.ACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants~Appellees. 2011-1325 Appea1 from the United States District C0urt for the Dist1'ict of DelaWare in case no. 08-CV-0330, Judge Sue L. RobinSon. ON MOTION ORDER Wats0n Pharmaceuticals, Inc., Watson Laborat0ries, Inc., and Watson Phar1na, Inc., move for a 30-day exten- sion of ti1ne, until May 4, 2012, to file their opening brief due to settlement negotiations Upon consideration thereof

CEPHALON V. WATSON PHARMA 2 IT ls ORDERED THA'1': The motion is granted No further extensions should be anticipated FOR THE COURT MAR 29 2012 /s/ Jan Horbaiy Date J an Horbaly C1erk ca william F. Le@, ESq. u.s.¢@uR¥B'F'EP»msmn JameS K. Str@nSk1, ESq. T“EFE°’M°'“°“‘T 521 |“|AR 29ZU12 .1AN HORBAl.¥ CLERK

Free access — add to your briefcase to read the full text and ask questions with AI

Cephalon, Inc. v. Watson Pharmaceuticals, Inc., (Fed. Cir. 2012).

Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Cephalon, Inc. v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.